Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 1;9(1):V5.
doi: 10.3171/2023.4.FOCVID2324. eCollection 2023 Jul.

Endoscopic endonasal approach for MRI-Negative Cushing's microadenoma

Jeffrey J Feng  1   2   3   4 , Stephanie K Cheok  1   2   3 , Alexander G Chartrain  1 , John D Carmichael  1   2   3 , Mark S Shiroishi  1   2   3 , William J Mack  1 , Gabriel Zada  1   2   3
Affiliations

Endoscopic endonasal approach for MRI-Negative Cushing's microadenoma

Jeffrey J Feng et al. Neurosurg Focus Video. .

Abstract

A 54-year-old male with a history of diabetes mellitus type 2 for 12 years and hypertension was seen in the clinic due to poorly controlled diabetes. Inferior petrosal sinus sampling (IPSS) confirmed Cushing's disease with primary adrenocorticotropic hormone (ACTH)-secreting pituitary adenoma on the right. However, 3T and subsequent 7T MRI showed no visible tumor. An endoscopic transsphenoidal approach was selected to explore the pituitary gland and resect the presumed microadenoma. Tumor was identified in the lateral recess along the right medial cavernous sinus wall and gross-total resection (GTR) was performed. The normal pituitary gland was preserved, and the patient went into remission. The video can be found here: https://stream.cadmore.media/r10.3171/2023.4.FOCVID2324.

Keywords: 7T MRI; MRI–Negative Cushing’s disease; cavernous sinus wall; pituitary adenoma; tumor resection.

PubMed Disclaimer

Conflict of interest statement

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this publication.The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this publication.

References

    1. Sharifi G, Amin AA, Sabahi M, et al. MRI–Negative Cushing’s disease: management strategy and outcomes in 15 cases utilizing a pure endoscopic endonasal approach. BMC Endocr Disord. 2022;22(1):154. - PMC - PubMed
    1. Newell-Price J, Pivonello R, Tabarin A, et al. Use of late-night salivary cortisol to monitor response to medical treatment in Cushing’s disease. Eur J Endocrinol. 2020;182(2):207–217. - PMC - PubMed
    1. Barrett TF, Dyvorne HA, Padormo F, et al. First application of 7-T magnetic resonance imaging in endoscopic endonasal surgery of skull base tumors. World Neurosurg. 2017;103:600–610. - PMC - PubMed
    1. Patel V, Liu CJ, Shiroishi MS, et al. Ultra-high field magnetic resonance imaging for localization of corticotropin-secreting pituitary adenomas. Neuroradiology. 2020;62(8):1051–1054. - PubMed
    1. Law M, Wang R, Liu CSJ, et al. Value of pituitary gland MRI at 7 T in Cushing’s disease and relationship to inferior petrosal sinus sampling: case report. J Neurosurg. 2019;130(2):347–351. - PMC - PubMed

LinkOut - more resources